LifeMD, Inc.
LifeMD, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash | 34 | - | 24 | 36 | 34 | 35 | 38 | 36 | 35 | 33 | 15 | 12 | |||||
Accounts Receivable Net Current | 10 | 9 | 9 | 7 | 10 | 10 | 6 | 6 | 5 | 5 | 4 | 4 | |||||
Deposits Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Inventory Net | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 4 | 4 | |||||
Other Assets Current | 4 | 3 | 4 | 2 | 2 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | |||||
Assets Current | 52 | 52 | 41 | 49 | 50 | 52 | 49 | 45 | 44 | 43 | 25 | 20 | |||||
Assets Noncurrent | |||||||||||||||||
Property Plant And Equipment Net | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 5 | 5 | 6 | 6 | 6 | 6 | 7 | 3 | 2 | 1 | 1 | 1 | |||||
Capitalized Computer Software Net | 11 | 11 | 15 | 15 | 14 | 9 | 13 | 13 | 12 | 12 | 11 | 10 | |||||
Finite Lived Intangible Assets Net | 0 | 0 | 2 | 2 | 2 | 0 | 2 | 3 | 3 | 3 | 3 | 4 | |||||
Assets Noncurrent | 18 | 19 | 25 | 25 | 24 | 24 | 24 | 19 | 17 | 16 | 16 | 15 | |||||
Assets | 70 | 70 | 66 | 74 | 74 | 76 | 73 | 64 | 61 | 58 | 41 | 35 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 22 | 14 | 20 | 24 | 16 | 11 | 16 | 15 | 12 | 11 | 10 | 10 | |||||
Accrued Liabilities Current | 15 | 16 | 22 | 15 | 19 | 22 | 21 | 15 | 15 | 14 | 15 | 15 | |||||
Notes Payable Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 | |||||
Operating Lease Liability Current | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |||||
Deferred Revenue | - | - | - | - | - | - | - | - | - | - | - | 6 | |||||
Convertible Debt Current | - | - | - | 12 | 12 | 8 | 5 | 6 | 4 | - | - | - | |||||
Deferred Revenue Current | 12 | 11 | 14 | 12 | 17 | 17 | 21 | 15 | 13 | 9 | 6 | 6 | |||||
Liabilities Current | 50 | 42 | 57 | 64 | 61 | 67 | 59 | 52 | 45 | 35 | 33 | 32 | |||||
Long Term Debt Noncurrent | |||||||||||||||||
Convertible Debt Noncurrent | - | - | - | 4 | 7 | 10 | 13 | 12 | 14 | 18 | 19 | 14 | |||||
Operating Lease Liability Noncurrent | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 2 | 1 | 0 | 0 | 0 | |||||
Business Combination Contingent Consideration Liab… | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 55 | 47 | 63 | 73 | 74 | 84 | 79 | 66 | 60 | 53 | 52 | 46 | |||||
Temporary Equity | |||||||||||||||||
Temporary Equity Carrying Amount Attributable To P… | - | - | - | - | - | - | - | - | - | - | - | 5 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 253 | 251 | 249 | 236 | 233 | 231 | 227 | 225 | 221 | 218 | 197 | 187 | |||||
Retained Earnings Accumulated Deficit | -238 | -229 | -248 | -238 | -236 | -240 | -235 | -229 | -222 | -214 | -210 | -203 | |||||
Treasury Stock Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Stockholders Equity | 15 | 23 | 1 | -2 | -5 | -8 | -8 | -4 | -1 | 6 | -11 | -16 | |||||
Minority Interest | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | |||||
Liabilities And Stockholders Equity | 70 | 70 | 66 | 74 | 74 | 76 | 73 | 64 | 61 | 58 | 41 | 35 | |||||
Temporary Equity Par Or Stated Value Per Share | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Temporary Equity Shares Authorized | - | - | - | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | - | - | 5 | 5 | 5 | 5 | |||||
Preferred Stock Liquidation Preference | 0 | 0 | - | - | - | 0 | - | - | - | - | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |||||
Common Stock Shares Issued | 143 | 140 | 140 | 135 | 131 | 127 | 126 | 125 | 122 | 115 | 104 | 98 | |||||
Shares Outstanding | 143 | 140 | 140 | 135 | 131 | 127 | 125 | 125 | 122 | 115 | 104 | 97 | |||||
Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -18.79% | -21.63% | -29.60% | - | - | - | - | - | - | - | - | - |
| 2025 | 57.35% | 77.19% | 37.76% | -47.72% | -45.69% | -46.79% | -28.12% | -18.39% | -33.62% | -10.23% | 27.88% | 9.46% |
| 2024 | -33.09% | -44.36% | -42.98% | -2.98% | -2.98% | -20.11% | 28.46% | 1.75% | 0.00% | -7.53% | 29.93% | 118.82% |
| 2023 | 16.94% | 137.70% | 149.18% | 16.12% | 70.77% | 72.68% | 8.38% | 15.78% | -18.02% | 20.50% | 57.36% | 3.77% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.04 | 1.25 | 0.73 | 0.77 | 0.82 | 0.78 | 0.83 | 0.87 | 0.99 | 1.22 | 0.77 | 0.64 | |||||
| Quick Ratio | 0.98 | 1.18 | 0.66 | 0.72 | 0.77 | 0.74 | 0.78 | 0.83 | 0.94 | 1.15 | 0.65 | 0.52 | |||||
| Working Capital | 2.11M | 10.26M | -15.58M | -14.51M | -10.93M | -15.03M | -10.30M | -6.58M | -266.33K | 7.82M | -7.64M | -11.34M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 3.66 | 2.04 | 47.64 | -41.05 | -13.53 | -11.07 | -10.17 | -15.66 | -71.17 | 9.51 | -4.67 | -2.85 | |||||
| Interest Coverage TTM | -15.26 | -5.41 | -4.00 | -4.37 | -7.13 | -9.38 | -8.51 | -8.19 | -6.34 | -5.58 | -8.05 | -11.26 | |||||
| Debt Ratio | 0.79 | 0.67 | 0.95 | 0.99 | 1.01 | 1.10 | 1.08 | 1.03 | 0.98 | 0.90 | 1.27 | 1.29 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 2.69 | 2.65 | 2.60 | 2.52 | 2.39 | 2.30 | 3.41 | 3.59 | 3.43 | 3.63 | 3.67 | 3.50 | |||||
| Days Sales Outstanding TTM | 18.92 | 18.58 | 15.50 | 13.70 | 17.54 | 18.55 | 9.90 | 9.56 | 9.23 | 9.70 | 9.35 | 8.77 | |||||
| Receivables Turnover TTM | 19.29 | 19.64 | 23.54 | 26.64 | 20.81 | 19.68 | 36.86 | 38.19 | 39.54 | 37.61 | 39.04 | 41.61 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 0.14 | 0.35 | -0.16 | -0.19 | -0.32 | -0.51 | -0.61 | -0.64 | -0.69 | -0.70 | -0.91 | -1.02 | |||||
| Free Cash Flow Per Share TTM | 0.08 | 0.14 | 0.23 | 0.40 | 0.32 | 0.39 | 0.49 | 0.38 | 0.42 | 0.25 | 0.03 | -0.09 | |||||
| Dividend Per Share TTM | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.08 | 0.07 | 0.08 | 0.08 | 0.09 | 0.09 | 0.10 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 86.81% | 85.72% | 83.46% | 84.18% | 84.54% | 86.15% | 89.64% | 88.92% | 88.21% | 87.61% | 87.03% | 86.36% | |||||
| Operating Profit Margin TTM | -7.97% | -3.95% | -4.44% | -5.78% | -9.54% | -13.18% | -9.66% | -10.78% | -10.89% | -9.50% | -16.71% | -19.58% | |||||
| Net Profit Margin TTM | 3.31% | 8.05% | -4.23% | -4.97% | -8.58% | -13.47% | -13.34% | -14.72% | -16.45% | -15.54% | -23.13% | -25.91% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 19.66% | 25.34% | -6.69% | -2.89% | -1.22% | 1.49% | 42.07% | 38.63% | 32.85% | 28.15% | 14.77% | 14.96% | |||||
| Net Income Growth (1Y) | -146.16% | -174.88% | -70.42% | -67.24% | -48.48% | -11.99% | -18.04% | -21.26% | -30.62% | -51.27% | -39.30% | -43.42% | |||||
| EPS Growth (1Y) | -142.06% | -168.35% | -73.07% | -69.53% | -53.13% | -27.57% | -32.76% | -37.92% | -43.99% | -55.48% | -45.53% | -46.47% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 26.70 | 9.85 | -41.16 | -70.35 | -16.93 | -9.78 | -8.55 | -10.80 | -14.99 | -11.86 | -6.86 | -4.25 | |||||
| P/B TTM | 11.36 | 6.65 | 238.48 | -339.26 | -42.90 | -26.99 | -28.52 | -67.35 | -477.24 | 50.50 | -19.44 | -8.84 | |||||
| P/S TTM | 0.88 | 0.79 | 1.74 | 3.49 | 1.45 | 1.32 | 1.14 | 1.59 | 2.47 | 1.84 | 1.59 | 1.10 | |||||
| Market Cap | 170.88M | 153.89M | 313.44M | 604.75M | 234.66M | 203.92M | 220.19M | 283.29M | 403.41M | 281.07M | 215.46M | 141.64M | |||||
| Enterprise Value | 136.41M | 153.89M | 289.66M | 584.00M | 221.14M | 187.25M | 200.83M | 265.73M | 386.44M | 266.18M | 219.42M | 144.00M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 3.80M | 6.41M | 10.72M | 17.92M | 13.97M | 16.05M | 20.78M | 15.57M | 16.29M | 8.62M | 1.03M | -2.81M | |||||
| Net Debt | -34.48M | 0.00 | -23.79M | -20.75M | -13.52M | -16.68M | -19.36M | -17.56M | -16.97M | -14.89M | 3.97M | 2.37M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
LifeMD, Inc. (LFMD) — SEC Financial Statements & Analysis
LifeMD, Inc. (LFMD) is a services-offices & clinics of doctors of medicine company, incorporated in DE. LifeMD, Inc. trades on LFMDP: Nasdaq as: LFMD: Nasdaq. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), LifeMD, Inc. reported a 19.66% year-over-year revenue growth, a Gross Profit Margin of 86.81% (TTM), a Debt-to-Equity ratio of 3.66x, a Price-to-Sales (P/S) ratio of 0.88x (TTM), a Price-to-Book (P/B) ratio of 11.36 (TTM), at a market cap of $170.88M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 19.66%
- Gross Profit Margin TTM
- 86.81%
- Debt To Equity
- 3.66x
- P/S TTM
- 0.88x
- P/B TTM
- 11.36
- Market Cap
- $170.88M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is LifeMD, Inc. in?
LifeMD, Inc. (LFMD) operates in the Services-Offices & Clinics of Doctors of Medicine industry.
What is LFMD's market cap?
LifeMD, Inc. (LFMD) has a market capitalization of $170.88M as of 2026-03-31.
What is LFMD's P/E ratio?
LifeMD, Inc. (LFMD)'s trailing twelve month P/E ratio is 26.70x as of 2026-03-31.
What exchange does LFMD trade on?
LifeMD, Inc. (LFMD) trades on the LFMDP: Nasdaq.
Where is LifeMD, Inc. incorporated?
LifeMD, Inc. is incorporated in DE.